Coronary artery bypass surgery perioperative management of myocardial dysfunction: Difference between revisions
Jump to navigation
Jump to search
Hardik Patel (talk | contribs) (/* 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT){{cite journal| author=Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al.| title=2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery...) |
Hardik Patel (talk | contribs) (/* Preconditioning/Management of Myocardial Ischemia (DO NOT EDIT){{cite journal| author=Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG et al.| title=2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of t...) |
||
Line 25: | Line 25: | ||
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | | colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Management targeted at optimizing the determinants of coronary arterial perfusion (eg, [[heart rate]], diastolic or [[mean arterial pressure]], and right ventricular or LV | | bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Management targeted at optimizing the determinants of coronary arterial perfusion (eg, [[heart rate]], diastolic or [[mean arterial pressure]], and right ventricular or LV end-diastolic pressure) is recommended to reduce the risk of perioperative [[myocardial ischemia]] and infarction.<ref name="pmid18290898">{{cite journal| author=Dyub AM, Whitlock RP, Abouzahr LL, Cinà CS| title=Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: a systematic review and meta-analysis. | journal=J Card Surg | year= 2008 | volume= 23 | issue= 1 | pages= 79-86 | pmid=18290898 | doi=10.1111/j.1540-8191.2007.00499.x | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18290898 }} </ref><ref name="pmid18223669">{{cite journal| author=Heusch G| title=Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. | journal=Br J Pharmacol | year= 2008 | volume= 153 | issue= 8 | pages= 1589-601 | pmid=18223669 | doi=10.1038/sj.bjp.0707673 | pmc=PMC2438254 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18223669 }} </ref><ref name="pmid3970360">{{cite journal| author=Slogoff S, Keats AS| title=Does perioperative myocardial ischemia lead to postoperative myocardial infarction? | journal=Anesthesiology | year= 1985 | volume= 62 | issue= 2 | pages= 107-14 | pmid=3970360 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3970360 }} </ref><ref name="pmid12392846">{{cite journal| author=Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al.| title=ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). | journal=J Am Coll Cardiol | year= 2002 | volume= 40 | issue= 8 | pages= 1531-40 | pmid=12392846 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12392846 }} </ref><ref name="pmid19909993">{{cite journal| author=Lavana JD, Fraser JF, Smith SE, Drake L, Tesar P, Mullany DV| title=Influence of timing of intraaortic balloon placement in cardiac surgical patients. | journal=J Thorac Cardiovasc Surg | year= 2010 | volume= 140 | issue= 1 | pages= 80-5 | pmid=19909993 | doi=10.1016/j.jtcvs.2009.09.033 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19909993 }} </ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|} | |} | ||
Revision as of 14:35, 9 November 2012
Coronary Artery Bypass Surgery Microchapters | |
Pathophysiology | |
---|---|
Diagnosis | |
Treatment | |
Perioperative Monitoring | |
Surgical Procedure | |
Special Scenarios | |
Coronary artery bypass surgery perioperative management of myocardial dysfunction On the Web | |
FDA on Coronary artery bypass surgery perioperative management of myocardial dysfunction | |
CDC on Coronary artery bypass surgery perioperative management of myocardial dysfunction | |
Coronary artery bypass surgery perioperative management of myocardial dysfunction in the news | |
Blogs on Coronary artery bypass surgery perioperative management of myocardial dysfunction|- |
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery (DO NOT EDIT)[1]
Perioperative Myocardial Dysfunction (DO NOT EDIT)[1]
Class IIa |
"1. In the absence of severe, symptomatic aorto-iliac occlusive disease or peripheral artery disease, the insertion of an intra-aortic balloon is reasonable to reduce mortality rate in CABG patients who are considered to be at high risk (eg, those who are undergoing reoperation or have LVEF <30% or left main CAD).[2][3][4][5][6][7] (Level of Evidence: B)" |
"2. Measurement of biomarkers of myonecrosis (eg, creatine kinase-MB, troponin) is reasonable in the first 24 hours after CABG.[8] (Level of Evidence: B)" |
Transfusion (DO NOT EDIT)[1]
Class I |
"1. Aggressive attempts at blood conservation are indicated to limit hemodilutional anemia and the need for intraoperative and perioperative allogeneic red blood cell transfusion in CABG patients.[9][10][11][12] (Level of Evidence: B)" |
Preconditioning/Management of Myocardial Ischemia (DO NOT EDIT)[1]
Class I |
"1. Management targeted at optimizing the determinants of coronary arterial perfusion (eg, heart rate, diastolic or mean arterial pressure, and right ventricular or LV end-diastolic pressure) is recommended to reduce the risk of perioperative myocardial ischemia and infarction.[13][14][15][16][17] (Level of Evidence: B)" |
Sources
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG; et al. (2011). "2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e31823c074e. PMID 22064599.
- ↑ Christenson JT, Cohen M, Ferguson JJ, Freedman RJ, Miller MF, Ohman EM; et al. (2002). "Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery". Ann Thorac Surg. 74 (4): 1086–90, discussion 1090-1. PMID 12400750.
- ↑ Christenson JT, Simonet F, Badel P, Schmuziger M (1999). "Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients". Ann Thorac Surg. 68 (3): 934–9. PMID 10509987.
- ↑ Christenson JT, Licker M, Kalangos A (2003). "The role of intra-aortic counterpulsation in high-risk OPCAB surgery: a prospective randomized study". J Card Surg. 18 (4): 286–94. PMID 12869172.
- ↑ Christenson JT, Schmuziger M, Simonet F (2001). "Effective surgical management of high-risk coronary patients using preoperative intra-aortic balloon counterpulsation therapy". Cardiovasc Surg. 9 (4): 383–90. PMID 11420164.
- ↑ Urban PM, Freedman RJ, Ohman EM, Stone GW, Christenson JT, Cohen M; et al. (2004). "In-hospital mortality associated with the use of intra-aortic balloon counterpulsation". Am J Cardiol. 94 (2): 181–5. doi:10.1016/j.amjcard.2004.03.058. PMID 15246896.
- ↑ Santa-Cruz RA, Cohen MG, Ohman EM (2006). "Aortic counterpulsation: a review of the hemodynamic effects and indications for use". Catheter Cardiovasc Interv. 67 (1): 68–77. doi:10.1002/ccd.20552. PMID 16342217.
- ↑ Yau JM, Alexander JH, Hafley G, Mahaffey KW, Mack MJ, Kouchoukos N; et al. (2008). "Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)". Am J Cardiol. 102 (5): 546–51. doi:10.1016/j.amjcard.2008.04.069. PMID 18721510.
- ↑ Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ; et al. (2006). "Transfusion in coronary artery bypass grafting is associated with reduced long-term survival". Ann Thorac Surg. 81 (5): 1650–7. doi:10.1016/j.athoracsur.2005.12.037. PMID 16631651.
- ↑ Surgenor SD, DeFoe GR, Fillinger MP, Likosky DS, Groom RC, Clark C; et al. (2006). "Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure". Circulation. 114 (1 Suppl): I43–8. doi:10.1161/CIRCULATIONAHA.105.001271. PMID 16820613.
- ↑ van Straten AH, Bekker MW, Soliman Hamad MA, van Zundert AA, Martens EJ, Schönberger JP; et al. (2010). "Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up". Interact Cardiovasc Thorac Surg. 10 (1): 37–42. doi:10.1510/icvts.2009.214551. PMID 19815567.
- ↑ van Straten AH, Kats S, Bekker MW, Verstappen F, ter Woorst JF, van Zundert AJ; et al. (2010). "Risk factors for red blood cell transfusion after coronary artery bypass graft surgery". J Cardiothorac Vasc Anesth. 24 (3): 413–7. doi:10.1053/j.jvca.2010.01.001. PMID 20231104.
- ↑ Dyub AM, Whitlock RP, Abouzahr LL, Cinà CS (2008). "Preoperative intra-aortic balloon pump in patients undergoing coronary bypass surgery: a systematic review and meta-analysis". J Card Surg. 23 (1): 79–86. doi:10.1111/j.1540-8191.2007.00499.x. PMID 18290898.
- ↑ Heusch G (2008). "Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents". Br J Pharmacol. 153 (8): 1589–601. doi:10.1038/sj.bjp.0707673. PMC 2438254. PMID 18223669.
- ↑ Slogoff S, Keats AS (1985). "Does perioperative myocardial ischemia lead to postoperative myocardial infarction?". Anesthesiology. 62 (2): 107–14. PMID 3970360.
- ↑ Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF; et al. (2002). "ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)". J Am Coll Cardiol. 40 (8): 1531–40. PMID 12392846.
- ↑ Lavana JD, Fraser JF, Smith SE, Drake L, Tesar P, Mullany DV (2010). "Influence of timing of intraaortic balloon placement in cardiac surgical patients". J Thorac Cardiovasc Surg. 140 (1): 80–5. doi:10.1016/j.jtcvs.2009.09.033. PMID 19909993.